Moreover, FDA is proposing two other constraints about the submission of the supplemental PMTA. Below proposed § 1114.15(a), a supplemental PMTA couldn't be submitted exactly where the advertising buy for the first tobacco product has become withdrawn or has long been quickly suspended or is the subject of temporary suspension or withdrawal proc